ResMed Inc, San Diego, had record revenue and income for the quarter ended June 30, 2009. Revenue for the quarter was $252.0 million, a 7% increase over the quarter ended June 30, 2008.
For the year ended June 30, 2009, revenue was $920.7 million, a 10% increase over the year ended June 30, 2008.
“Masks launched in fiscal 2009, including the Swift™ LT, Swift LT for Her, and the Activa™ LT, were strong drivers of growth as was the Quattro,” said Kieran T. Gallahue, president and CEO of ResMed. “The fact that the market for sleep disordered breathing therapy remains highly underpenetrated and the drive to increase the awareness of SDB and improve patient compliance seem to have shielded us from the economic factors affecting many other companies.”
